STERIS (NYSE:STE) Stock Unloaded Rep. Jared Moskowitz

Representative Jared Moskowitz (Democratic-Florida) recently sold shares of STERIS plc (NYSE:STE). In a filing disclosed on August 27th, the Representative disclosed that they had sold between $1,001 and $15,000 in STERIS stock on July 13th. The trade occurred in the Representative’s “MORGAN STANLEY ACTIVE ASSETS (1)” account.

Representative Jared Moskowitz also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of W.W. Grainger (NYSE:GWW) on 7/13/2026.
• Purchased $1,001 – $15,000 in shares of Applied Materials (NASDAQ:AMAT) on 7/13/2026.
• Purchased $1,001 – $15,000 in shares of Applied Materials (NASDAQ:AMAT) on 6/18/2026.
• Purchased $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 6/17/2026.
• Purchased $1,001 – $15,000 in shares of HCA Healthcare (NYSE:HCA) on 6/17/2026.
• Purchased $1,001 – $15,000 in shares of Home Depot (NYSE:HD) on 6/17/2026.
• Purchased $1,001 – $15,000 in shares of Monster Beverage (NASDAQ:MNST) on 6/17/2026.
• Sold $1,001 – $15,000 in shares of S&P Global (NYSE:SPGI) on 6/17/2026.
• Purchased $1,001 – $15,000 in shares of Meta Platforms (NASDAQ:META) on 6/17/2026.
• Purchased $1,001 – $15,000 in shares of SpaceX (NASDAQ:SPCX) on 6/12/2026.

STERIS Trading Up 0.4%

Shares of STE opened at $230.56 on Thursday. The stock’s fifty day simple moving average is $224.83 and its 200-day simple moving average is $222.42. The firm has a market capitalization of $22.48 billion, a PE ratio of 28.19 and a beta of 0.91. STERIS plc has a 12-month low of $195.14 and a 12-month high of $269.44. The company has a quick ratio of 1.35, a current ratio of 1.91 and a debt-to-equity ratio of 0.23.

STERIS (NYSE:STE) last announced its quarterly earnings data on Wednesday, August 5th. The medical equipment provider reported $2.59 earnings per share for the quarter, topping the consensus estimate of $2.49 by $0.10. The firm had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.49 billion. STERIS had a return on equity of 14.34% and a net margin of 13.34%.The company’s quarterly revenue was up 7.3% compared to the same quarter last year. During the same period in the previous year, the business posted $2.34 EPS. STERIS has set its FY 2027 guidance at 11.000-11.300 EPS. As a group, research analysts predict that STERIS plc will post 11.09 earnings per share for the current year.

STERIS Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Friday, September 4th will be paid a dividend of $0.69 per share. This represents a $2.76 annualized dividend and a dividend yield of 1.2%. This is a boost from STERIS’s previous quarterly dividend of $0.63. The ex-dividend date of this dividend is Friday, September 4th. STERIS’s payout ratio is currently 33.74%.

Analysts Set New Price Targets

A number of equities analysts have issued reports on STE shares. Piper Sandler reaffirmed an “overweight” rating and issued a $275.00 price objective (up from $270.00) on shares of STERIS in a research note on Friday, August 7th. KeyCorp cut their price target on STERIS from $291.00 to $269.00 and set an “overweight” rating on the stock in a research note on Wednesday, May 13th. Wall Street Zen upgraded STERIS from a “hold” rating to a “buy” rating in a research report on Sunday, August 9th. UBS Group decreased their price objective on STERIS from $275.00 to $270.00 and set a “buy” rating for the company in a research note on Friday, August 7th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of STERIS in a report on Monday, August 24th. Three investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $271.33.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. California State Teachers Retirement System increased its holdings in STERIS by 20,515.0% during the 2nd quarter. California State Teachers Retirement System now owns 35,267,316 shares of the medical equipment provider’s stock worth $7,426,239,000 after purchasing an additional 35,096,240 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of STERIS by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 12,286,535 shares of the medical equipment provider’s stock worth $3,114,882,000 after buying an additional 73,014 shares during the period. State Street Corp boosted its position in shares of STERIS by 6.0% during the fourth quarter. State Street Corp now owns 4,614,840 shares of the medical equipment provider’s stock worth $1,169,957,000 after buying an additional 260,001 shares during the period. Wellington Management Group LLP grew its holdings in shares of STERIS by 21.9% during the second quarter. Wellington Management Group LLP now owns 3,502,897 shares of the medical equipment provider’s stock worth $737,605,000 after buying an additional 629,532 shares in the last quarter. Finally, Geode Capital Management LLC raised its position in STERIS by 0.6% in the 4th quarter. Geode Capital Management LLC now owns 2,523,620 shares of the medical equipment provider’s stock valued at $637,259,000 after buying an additional 14,151 shares during the last quarter. 94.69% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, VP John Adam Zangerle sold 1,419 shares of the firm’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $209.28, for a total value of $296,968.32. Following the completion of the sale, the vice president directly owned 35,259 shares in the company, valued at approximately $7,379,003.52. This trade represents a 3.87% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Mohsen Sohi sold 4,058 shares of STERIS stock in a transaction that occurred on Wednesday, August 12th. The stock was sold at an average price of $235.78, for a total value of $956,795.24. Following the transaction, the director owned 24,305 shares of the company’s stock, valued at $5,730,632.90. This represents a 14.31% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 6,851 shares of company stock valued at $1,545,052 in the last quarter. 1.12% of the stock is currently owned by insiders.

About Representative Moskowitz

Jared Evan Moskowitz (Democratic Party) is a member of the U.S. House, representing Florida’s 23rd Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027.

Moskowitz (Democratic Party) is running for re-election to the U.S. House to represent Florida’s 23rd Congressional District. He declared candidacy for the 2026 election.

Jared Evan Moskowitz was born in Coral Springs, Florida. Moskowitz graduated from Marjory Stoneman Douglas High School. He earned a bachelor’s degree in political science and government from George Washington University in 2003 and a law degree from Nova Southeastern University in 2007. Moskowitz’s career experience includes working as the director of the Florida Division of Emergency Management and general counsel with AshBritt Inc.

STERIS Company Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.